Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Feb 4 2022

Full Issue

Viewpoints: Protocol Allows Allergic Patients To Receive Covid Vaccine; The Downside Of The End Of The Pandemic

Opinion writers weigh in on these covid issues.

Scientific American: COVID Vaccines Can Be Safe For People With Prior Allergic Reactions 

Despite the availability and efficacy of COVID vaccines, many people with a history of suspected allergies to the first mRNA COVID vaccine dose—reactions such as hives, swelling, shortness of breath and/or low blood pressure—have not gotten their full series. Their fear is understandable. After all, the U.S. Centers for Disease Control and Prevention currently states that there are two contraindications to the COVID vaccine: “severe allergic reaction (e.g., anaphylaxis) after a previous dose or to a component of the COVID-19 vaccine,” and “known diagnosed allergy to a component of the COVID-19 vaccine.” Yet as an allergist/immunologist who has been seeing such patients on a daily basis for the past year, I believe that the CDC is wrong and should change its guidelines. (Charles Feng, 2/3)

The New York Times: The End Of The Pandemic May Tear Us Apart 

For countries with high vaccination rates, 2022 may be the last year when strong measures are required against Covid-19. The end of the pandemic, however, will not come easily. One might imagine that the end of the emergency would be joyfully welcomed. But conflicts over whether schools should remain open and the value of mask mandates reveal that just because the prognosis for Covid-19 has improved does not mean that public officials are absolved from the need to make hard choices about policy. A waning pandemic does not mean the end of leadership on Covid, but may instead mean it’s more necessary than ever. (Michael Bang Peterson, 2/4)

Bloomberg: Returning To Normal Life After Covid Will Require Vigilance

For the first time in a long while, there’s good news about Covid-19. The omicron wave is cresting in the U.S., and in many states is already receding. A respite from SARS-CoV-2 could well follow. And if new variants eventually emerge, it may be possible to live with them — that is, without shutting businesses, always wearing masks, and social distancing. A return to normal ... will require careful monitoring, better data collection, and a nationwide effort to prevent another crisis. (2/3)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF